ASPS Addresses Concerns Regarding BOTOX Treatments

The American Society of Plastic Surgeons (ASPS) addressed concerns regarding the use of botulinum toxin products and adverse events following a recent petition from a consumer group. On January 23, Public Citizen requested the U.S. Food and Drug Administration (FDA) implement labeling changes and a written communication to physicians. More than one million people have been treated with BOTOX Cosmetic.

More: continued here

Filed under: Cosmetic Medicine on January 29th, 2008